Sanofi (SNY) Total Debt (2009 - 2025)

Sanofi has disclosed Total Debt across 17 years of filings, most recently posting $21.6 billion for Q4 2025.

• Total Debt for Q4 2025 came in at $21.6 billion, up 26.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.6 billion (up 26.57% YoY), and the FY2025 annual result was $21.6 billion, up 26.57% from the prior year.
• Total Debt came in at $21.6 billion for Q4 2025 at Sanofi, down from $23.2 billion in the prior quarter.
• In the past five years, Total Debt ranged from a high of $24.3 billion in Q2 2021 to a low of $17.1 billion in Q4 2024.
• The 5-year median for Total Debt is $21.1 billion (2023), against an average of $21.1 billion.
• Across the five-year window, Total Debt declined 16.47% in 2022 and increased 26.57% in 2025, its largest moves.
• Sanofi's Total Debt stood at $23.2 billion in 2021, then decreased by 16.42% to $19.4 billion in 2022, then fell by 9.17% to $17.6 billion in 2023, then declined by 3.06% to $17.1 billion in 2024, then increased by 26.57% to $21.6 billion in 2025.
• The last three Total Debt figures came in at $21.6 billion (Q4 2025), $23.2 billion (Q2 2025), and $17.1 billion (Q4 2024), per Business Quant data.